Literature DB >> 32716837

The importance of Mediterranean fever gene in familial Mediterranean fever.

Demet Yalçın Kehribar1, Metin Özgen2.   

Abstract

OBJECTIVE: Familial Mediterranean fever (FMF) is the most common autoinflammatory disease characterized by recurrent serositis attacks and fever. The discovery of the Mediterranean fever (MEFV) gene has been a milestone in FMF etiopathogenesis. Our knowledge about the relationship between the MEFV gene and FMF phenotype increases each day. This study aims to investigate the relationship between MEFV gene mutations and the FMF clinical findings of a single-center FMF cohort.
METHODS: Gender, age, age at symptom onset, age at diagnosis, clinical characteristics, and MEFV gene analysis of the patients were recorded.
RESULTS: A total of 837 FMF patients were included in this study. There were 515 females and 322 males. The age at symptom onset was 18.3±10.9 years, while the age at diagnosis was 24.4±10.9 years. The most common symptom that accompanied fever was peritonitis (91.1%), while the other common clinical findings were pleuritis (45%), myalgia (44%), and arthritis (36%). A total of 47 patients developed amyloidosis. A total of 553 (66%) FMF patients had M694V mutation, 221 (26%) of which were homozygous, while 332 (40%) were heterozygous. Exon 10 mutation frequency was 759 (91%), while the non-exon 10 mutation frequency was 78 (9%). There was no wild type among the patients.
CONCLUSION: In conclusion, the fact that a vast majority of the disease burden was constituted by the exon 10, especially M694V mutations and that none of the 837 patients from our cohort had a wild-type FMF proved the significance of MEFV gene mutation analysis. Therefore, we speculate that it is necessary to examine the MEFV gene mutations in each FMF suspected case. It seems plausible to re-evaluate the FMF diagnosis for cases in which a wild type MEFV gene mutation occurs.

Entities:  

Year:  2020        PMID: 32716837      PMCID: PMC7574771          DOI: 10.5152/eurjrheum.2020.20107

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  23 in total

Review 1.  Familial Mediterranean fever, review of the literature.

Authors:  Mansour Alghamdi
Journal:  Clin Rheumatol       Date:  2017-06-18       Impact factor: 2.980

2.  Colchicine for familial Mediterranean fever.

Authors:  S E Goldfinger
Journal:  N Engl J Med       Date:  1972-12-21       Impact factor: 91.245

Review 3.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

4.  A candidate gene for familial Mediterranean fever.

Authors: 
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

5.  Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study.

Authors:  Mehmet Tunca; Servet Akar; Fatos Onen; Huri Ozdogan; Ozgur Kasapcopur; Fatos Yalcinkaya; Ercan Tutar; Seza Ozen; Rezan Topaloglu; Engin Yilmaz; Mustafa Arici; Aysin Bakkaloglu; Nesrin Besbas; Tekin Akpolat; Ayhan Dinc; Eren Erken
Journal:  Medicine (Baltimore)       Date:  2005-01       Impact factor: 1.889

6.  Familial mediterranean fever: assessment of clinical manifestations, pregnancy, genetic mutational analyses, and disease severity in a national cohort.

Authors:  Hatice Bodur; Fatma Gül Yurdakul; Hasan Fatih Çay; Ülkü Uçar; Yaşar Keskin; Betül Sargın; Gülcan Gürer; Ozan Volkan Yurdakul; Mustafa Çalış; Hülya Deveci; Yıldıray Aydın; Sami Hizmetli; Remzi Çevik; Ali Yavuz Karahan; İsmihan Sunar; Mehmet Tuncay Duruöz; Hilal Ecesoy; Zafer Günendi; Murat Toprak; Nesrin Şen; Duygu Altıntaş; Ahmet Kıvanç Cengiz; Gökhan Çağlayan; Ali Nail Demir; Hüseyin Kaplan; Sertaç Ketenci; Meltem Alkan Melikoğlu; Mehmet Nayimoğlu; Kemal Nas; Ayşe Banu Sarıfakıoğlu; İlhan Sezer
Journal:  Rheumatol Int       Date:  2019-09-14       Impact factor: 2.631

7.  Guidelines for the genetic diagnosis of hereditary recurrent fevers.

Authors:  Y Shinar; L Obici; I Aksentijevich; B Bennetts; F Austrup; I Ceccherini; J M Costa; A De Leener; M Gattorno; U Kania; I Kone-Paut; S Lezer; A Livneh; I Moix; R Nishikomori; S Ozen; L Phylactou; L Risom; D Rowczenio; T Sarkisian; M E van Gijn; M Witsch-Baumgartner; M Morris; H M Hoffman; I Touitou
Journal:  Ann Rheum Dis       Date:  2012-06-01       Impact factor: 19.103

Review 8.  The Broad-Ranging Panorama of Systemic Autoinflammatory Disorders with Specific Focus on Acute Painful Symptoms and Hematologic Manifestations in Children.

Authors:  Donato Rigante
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-11-01       Impact factor: 2.576

9.  The distribution of MEFV mutations in Turkish FMF patients:zzm321990multicenter study representing results of Anatolia

Authors:  Şule Yaşar Bilge; İsmail Sarı; Dİlek Solmaz; Soner Şenel; Hakan Emmungil; Levent Kılıç; Sibel Yılmaz Öner; Fatih Yıldız; Sedat Yılmaz; Duygu Ersözlü Bozkırlı; Müge Aydın Tufan; Sema Yılmaz; Veli Yazısız; Yavuz Pehlivan; Cemal Bes; Gözde Yıldırım Çetin; Şükran Erten; Emel Gönüllü; Fezan Şahin; Servet Akar; Kenan Aksu; Umut Kalyoncu; Haner Direskeneli; Eren Erken; Bünyamin Kısacık; Mehmet Sayarlıoğlu; Muhammed Çınar; Timuçin Kaşifoğlu
Journal:  Turk J Med Sci       Date:  2019-04-18       Impact factor: 0.973

10.  Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in Japan.

Authors:  Yushiro Endo; Tomohiro Koga; Midori Ishida; Yuya Fujita; Sosuke Tsuji; Ayuko Takatani; Toshimasa Shimizu; Remi Sumiyoshi; Takashi Igawa; Masataka Umeda; Shoichi Fukui; Ayako Nishino; Shin-Ya Kawashiri; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Kazunaga Agematsu; Akihiro Yachie; Junya Masumoto; Kiyoshi Migita; Atsushi Kawakami
Journal:  Arthritis Res Ther       Date:  2018-11-20       Impact factor: 5.156

View more
  1 in total

1.  Phenotypic characterization of Familial Mediterranean Fever patients harboring variants of uncertain significance

Authors:  Alper Sarı; Erdal Bodakçi; Berkan Armağan; Hasan Satış; Nuh Ataş; Nazife Şule Yaşar Bilge; Reyhan Bilici Salman; Gözde Kübra Yardımcı; Hakan Babaoğlu; Levent Kılıç; Mehmet Akif Öztürk; Şeminur Haznedaroğlu; Berna Göker; Umut Kalyoncu; Timuçin Kaşifoğlu; Abdurrahman Tufan
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.